Skip to content

Advertisement

  • Short report
  • Open Access

Infection of novel reassortant H1N2 and H3N2 swine influenza A viruses in the guinea pig model

Veterinary Research201849:73

https://doi.org/10.1186/s13567-018-0572-4

  • Received: 11 April 2018
  • Accepted: 18 July 2018
  • Published:

Abstract

Novel H1N2 and H3N2 swine influenza A viruses (IAVs) were identified in commercial farms in Chile. These viruses contained H1, H3 and N2 sequences, genetically divergent from IAVs described worldwide, associated with pandemic internal genes. Guinea pigs were used as human surrogate to evaluate the infection dynamics of these reassortant viruses, compared with a pandemic H1N1 virus. All viruses replicated and were shed in the upper respiratory tract without prior adaptation although H1N2 viruses showed the highest shedding titers. This could have public health importance, emphasizing the need to carry out further studies to evaluate the zoonotic potential of these viruses.

Introduction, methods and results

Influenza A virus (IAV) has economic and public health relevance, being considered ubiquitous in the swine industry worldwide [1, 2]. There was limited information about IAVs circulating in swine population around the world, but the pandemic H1N1 (pdmH1N1) lineage that emerged in 2009 underscored the need to increase the surveillance and research of IAV in swine (IAV-S) [3]. In Chile, novel IAVs-S of the H1 and H3 subtypes have been recently identified in commercial swine farms, which are genetically divergent from IAVs described in other countries. These novel IAV-S lineages were most closely related to human seasonal H1N1 and H3N2 viruses from the late 1980s and early 1990s and were named: Chile H1 human I, Chile H1 human II, Chile H3 human I, and Chile H3 human II [4]. To date, phylogenetic analyses have been based on hemagglutinin (HA) sequences only, highlighting the need for additional studies to fully characterize these viruses, including the evaluation of their zoonotic potential.

Different animal models have been used for the study of IAVs, with guinea pigs, ferrets and mice being the most frequently used. Guinea pigs have several advantages compared to ferrets, such as their commercial availability, small size, low cost, and their ease of handling and housing, which make them an attractive model for IAV. In addition, they have been shown to have a high susceptibility to low-passage human isolates, in contrast to mice, in which virus adaptation is usually required for efficient infection [5, 6]. Guinea pigs have been used to assess the 2009 pdmH1N1 [7, 8] and seasonal H1N1 and H3N2 human influenza viruses [9, 10], because the anatomy and physiology of the guinea pig respiratory system resembles that of humans [11]. However, few studies have used this animal model to assess novel IAVs-S circulating on commercial farms worldwide, which may pose a risk to human public health. Hence, we evaluated the replication kinetics and shedding of novel reassortant H1N2 and H3N2 IAVs-S in the guinea pig model, compared with a pdmH1N1 virus.

We isolated pdmH1N1, H1N2 and H3N2 IAVs-S during passive and active surveillance carried out on Chilean commercial swine farms in 2014–2015. Thirty-two farms belonging to 22 companies, which represent >90% of the pig inventory in Chile, were enrolled in the study. The farms were integrated one-site or multi-site farming systems with greater than 800 sows in the farrowing units.

Briefly, TRIzol® LS Reagent (Invitrogen™, Carlsbad, CA, USA) was used to isolate RNA from nasal swab or oral fluid samples, and a real time RT-PCR based on highly conserved regions of the IAV matrix (M) gene was carried out [12]. Positive RT-PCR samples were inoculated in Madin-Darby Canine Kidney (MDCK) cell monolayers and were incubated for 1 h at 37 °C to allow virus absorption. Cells were then rinsed with 1× phosphate-buffered saline (PBS) to remove unbound virus, and IAV growth medium (MEM supplemented with 1 μg/mL of trypsin treated with N-tosyl-l-phenylalanyl chloromethyl ketone (TPCK), 0.3% bovine serum albumin, and 1% antibiotic–antimycotic solution) was added. The monolayers were incubated at 37 °C and observed for cytopathic effect (CPE) daily for 5 days.

The HA gene sequences of isolated IAVs-S were obtained by Sanger sequencing, which was performed at Veterinary Diagnostic Laboratory, University of Minnesota, Saint Paul, MN, USA. Sequence alignment of the HA gene was carried out with MUSCLE and phylogenetic trees were constructed with the Maximum likelihood method and a General Time Reversible model with a variation rate among sites given by gamma distribution with invariant sites (GTR + G+I), using MEGA v7.0 software. Reference sequences of swine and human influenza viruses were selected from GenBank [13], and from searches using BLAST [14] and the Influenza Research Database [15]. Bootstrap values were determined with 1000 replicates of the dataset. The new swine H1 clade classification tool was used to determine the identity of H1 viruses [15, 16].

HA sequences were clustered within the lineages Chile H1 human I, Chile H1 human II, Pandemic—Chile 2 and Chile H3 human I, previously described by Nelson et al. [4]. We selected 1 virus per lineage (4 viruses in total): A/swine/Chile/VN1401-4/2014(H1N2), A/swine/Chile/VN1401-274/2014(H1N2), A/swine/Chile/VN1401-559/2014(H1N1), and A/swine/Chile/VN1401-1824/2015(H3N2), respectively. According to the H1 classification described by Anderson et al. [16], the strains A/swine/Chile/VN1401-4/2014(H1N2) and A/swine/Chile/VN1401-274/2014(H1N2) were classified within the human seasonal lineage 1B.2, while the strain A/swine/Chile/VN1401-559/2014(H1N1) was classified within the pdmH1N1 lineage (1A.3.3.2). Chilean H1 and H3 sequences were most closely related to human seasonal H1N1 and H3N2 IAVs, respectively, from the late 1980s and early 1990s. The H1N2 and H3N2 viruses were grouped in independent monophyletic clusters, genetically distant from IAVs identified in swine and humans globally (Figures 1, 2, Additional files 1 and 2).
Figure 1
Figure 1

Phylogenetic trees based on HA sequences of subtype H1. Maximum Likelihood method and General Time Reversible model with a variation rate among sites given by gamma distribution with invariant sites (GTR + G + I) were used. Human and swine reference sequences are in black. Branches of Chilean IAVs-S sequences are in red, and nodes of selected viruses for guinea pig infection are highlighted with a red circle.

Figure 2
Figure 2

Phylogenetic trees based on HA sequences of subtype H3. Maximum Likelihood method and General Time Reversible model with a variation rate among sites given by gamma distribution with invariant sites (GTR + G + I) were used. Human and swine reference sequences are in black. Branches of Chilean IAVs-S sequences are in red, and the node of the selected virus for guinea pig infection is highlighted with a red circle. The closest related sequences to the Chilean H3 IAV-S correspond to human sequences, which are highlighted in blue.

Whole genome sequencing of selected IAVs-S was performed at the Sequencing Core Laboratory of the Center for Research on Influenza Pathogenesis (CRIP), Icahn School of Medicine at Mount Sinai, New York City, NY, USA. Briefly, all viral segments were amplified by a multisegment reverse transcription-PCR (M-RTPCR), following a previously described protocol [17]. Multiplexed libraries were prepared and sequenced on an Illumina HiSeq 2500 platform in a single-end 100 nt run format, and the viral genomes were assembled de novo. The neuraminidase (NA) segment was evaluated by the same phylogenetic analysis previously described for the HA segment. Internal gene sequences were submitted to BLAST to reveal the closest sequences for each segment.

The Chilean N2 sequences were most closely related to human seasonal H3N2 IAVs from the late 1980s and early 1990s. These sequences were grouped in independent monophyletic clusters, genetically divergent from IAVs described in other countries. The N2 sequences of H1N2 viruses were genetically distant (13%) from that of H3N2 virus (Additional file 3). On the other hand, the N1 segment was closely related to pdmH1N1 viruses (up to 98% identity). All viruses contained internal genes derived from the pdmH1N1. The GenBank accession numbers for these sequences are provided in Additional file 4.

The four selected viruses were propagated in MDCK cells, aliquoted and stored at −80 °C until used. Viruses were then titrated in triplicate by median tissue culture infective dose (TCID50) assay. Briefly, confluent MDCK cells in 96-well plates were washed three times with 150 μL of PBS containing 1 µg/mL of TPCK-treated trypsin and inoculated with 100 µL of ten-fold serial dilutions of each virus (4 replicates per virus dilution). The cells were incubated at 37 °C and observed for CPE daily for 5 days. The virus titer was expressed in TCID50/mL according to the Reed-Muench method [18]. Immediately before the inoculation of animals, each virus was diluted to 105 TCID50/300 µL in PBS containing 100 units/mL penicillin G, 100 µg/mL streptomycin sulfate, 250 ng/mL amphotericin B and 0.3% bovine serum albumin (PBS-PSA-BSA). This titer was confirmed by back-titration (TCID50 assay).

Twenty-four Pirbright strain guinea pigs were obtained from the Instituto de Salud Pública de Chile. They were acclimated for a week on a 12 h light/dark cycle and were allowed access to food and water ad libitum. Animals were then randomly separated into four groups of six animals each, which were inoculated intranasally with 300 µL of PBS-PSA-BSA containing 105 TCID50 of each selected virus. Prior to virus inoculation and sample collections, the guinea pigs were anesthetized intramuscularly with a mixture of ketamine (30 mg/kg) and xylazine (2 mg/kg) [9]. Nasal washings were collected from animals on 1, 3, 5, 7, 9, and 11 days post-inoculation (dpi) by instilling 1 mL of PBS-PSA-BSA into the nostrils. Samples were centrifuged for 8 min at 6000 × g and 4 °C and the supernatants were stored at −80 °C. Serum samples were obtained from each animal at 0 (prior to inoculation) and 11 dpi (euthanasia). Procedures were conducted in biosafety level-2 (BSL-2) conditions and were approved by Institutional Animal Care and Use Committees of the Universidad de Chile, under protocol number 02-2016.

An ELISA to detect antibodies against IAVs was performed on serum samples, according to the manufacturer’s instructions (IDEXX Influenza A Ab Test, IDEXX Laboratories, Inc., Westbrook, ME, USA). The virus titration of each nasal wash sample was calculated by the TCID50 assay described above. Viral titers were compared among animal groups in each sampling time, and area under the curve (AUC) was calculated to compare the total shedding among virus strains. Kruskal–Wallis test followed by Dunn’s multiple comparisons test was performed for these analyzes, using the RStudio software (version 1.1.383). Statistical analysis of infection curves was performed by Mantel-Cox test, using GraphPad Prism 5 software (version 5.01). A P value of < 0.05 was considered statistically significant.

Guinea pigs were seronegative to IAV at 0 dpi (Additional file 5). All viruses were able to infect guinea pigs, reaching a peak at 3 dpi with an average nasal viral load of 106.7 TCID50/mL for A/swine/Chile/VN1401-4/2014(H1N2), 106.4 TCID50/mL for A/swine/Chile/VN1401-274/2014(H1N2), 105.3 TCID50/mL for A/swine/Chile/VN1401-559/2014(H1N1) and 105.6 TCID50/mL for A/swine/Chile/VN1401-1824/2015(H3N2). The strains A/swine/Chile/VN1401-4/2014(H1N2) and A/swine/Chile/VN1401-274/2014(H1N2) showed higher viral titers than strains A/swine/Chile/VN1401-559/2014(H1N1) and A/swine/Chile/VN1401-1824/2015(H3N2) on 1 and 3 dpi (P < 0.05). The overall shedding during the experiment was statistically higher (P < 0.05) in animals infected with strains A/swine/Chile/VN1401-4/2014(H1N2) and A/swine/Chile/VN1401-274/2014(H1N2) than those infected with strains A/swine/Chile/VN1401-559/2014(H1N1) and A/swine/Chile/VN1401-1824/2015(H3N2) (Figure 3). Moreover, 1 of 6 animals inoculated with the pdmH1N1 virus did not show viral titers at 1 dpi. However, there was no statistical difference in the infection rate among the different groups (P = 0.94) (Figure 4).
Figure 3
Figure 3

Replication kinetics of novel reassortant IAVs-S in the guinea pig model. Groups of 6 guinea pigs were intranasally inoculated with 105 TCID50 of either A/swine/Chile/VN1401-4/2014(H1N2), A/swine/Chile/VN1401-274/2014(H1N2), A/swine/Chile/VN1401-559/2014(H1N1) or A/swine/Chile/VN1401-1824/2015(H3N2) viruses. Nasal wash samples were collected on 1, 3, 5, 7, and 9 dpi, and viral titers were determined by TCID50 assay. Data are shown as mean ± SD. Horizontal dashed line represents the limit of detection of the assay (101.5 TCID50/mL).

Figure 4
Figure 4

Infection dynamics of novel reassortant IAVs-S in the guinea pig model. Infection curves indicate de percent of animals that were found to be positive by TCID50 assay after inoculation with either A/swine/Chile/VN1401-4/2014(H1N2), A/swine/Chile/VN1401-274/2014(H1N2), A/swine/Chile/VN1401-559/2014(H1N1) or A/swine/Chile/VN1401-1824/2015(H3N2) viruses. Viral infection was determined on six guinea pigs per group on 1, 3, 5, 7, and 9 dpi.

The seroconversion rates, determined by ELISA at 11 dpi, were higher in animals inoculated with A/swine/Chile/VN1401-4/2014(H1N2) (6 out of 6) and A/swine/Chile/VN1401-274/2014(H1N2) (4 out of 6) than those inoculated with A/swine/Chile/VN1401-559/2014(H1N1) (2 out of 6) and A/swine/Chile/VN1401-1824/2015(H3N2) (2 out of 6) (Additional file 5). Note that all animals were infected, and that the ELISA test was only performed to assess the percentage of early seroconverted animals at the end of the experiment (11 dpi), since at that time point it is premature to determine overall seroconversion [19].

The viral load decreased by 5 dpi, and most of the animals became negative by 7 dpi, except for 2 animals infected with the A/swine/Chile/VN1401-1824/2015(H3N2) virus. The viral clearance was observed in all groups between 7 and 9 dpi (Figure 3).

Discussion

These results demonstrate that novel reassortant H1N2 and H3N2 IAVs-S with pandemic internal genes were able to infect, replicate and be shed efficiently in the upper respiratory tract of guinea pigs without prior adaptation. These viruses were compared with a pdmH1N1 virus, lineage that has been well studied in the guinea pig model since its emergence in 2009 [7, 8, 20]. Overall, all viruses had similar shedding kinetics except that both H1N2 viruses showed higher shedding titers than pdmH1N1 and H3N2 viruses. On the other hand, only animals inoculated with the H3N2 virus showed titers at 7 dpi. Using guinea pig model, Sun et al. [21] reported similar shedding kinetics for H1N2 and H3N2 IAVs-S isolated in 2006 in China and a pdmH1N1 virus isolated from human in 2009, where H3N2 IAVs-S took a longer time to clear from the nasopharyngeal cavity than pdmH1N1 and seasonal human viruses.

This is of importance, since the respiratory system of guinea pigs has anatomical and physiological characteristics comparable to those of humans [11] along with a similar IAV receptor distribution [21]. Hence, these results suggest that these novel reassortant IAVs-S might be capable of replicating efficiently in other mammal hosts, such as humans.

Some cases of zoonotic human infections with swine-origin H1N2 and H3N2 variants, which contain a pandemic M gene, have been reported in North America [22, 23]. The pandemic M gene has been hypothesized as a critical factor in these zoonotic events, because it is thought to contribute to increased IAV transmission [20]. In addition to the pandemic internal genes, the H1N2 and H3N2 IAVs-S reported here also have human-origin HA genes [4], which may lead to an increase in the risk of human-to-human transmission if they are introduced back into humans. Recently, a pig farm worker became infected with a reassortant H1N2 IAV-S in Brazil (lineage 1B.2.2). This virus also had a human-origin HA (introduced into swine in the late 1990s) and pandemic internal genes [24]. Notably, H1N2 viruses have been frequently detected in Chilean commercial swine farms [4], underscoring the risk of this strain as a potential zoonotic virus.

Recently a Chilean H1N2 strain was detected in a backyard farm in 2014 [25], which unexpectedly had 100% of nucleotide identity with the HA and internal genes of A/swine/Chile/VN1401-4/2014(H1N2) strain used in this study. This lineage has frequently been found in commercial swine farms since 2012 [4]. Hence, one plausible explanation is that the backyard farm virus could be a result of a spillover event from a commercial farm, a situation that has been reported in Chile for other swine viruses such as porcine reproductive and respiratory syndrome virus [26].

There exist other animal models for IAV research, such as mouse and ferret. The main drawback to the mouse model is the need to use mouse-adapted viruses in order to achieve productive infection [6]. Bravo-Vasquez et al. [25] obtained a lower average nasal titer (103.5 TCID50 approx.) at 3 dpi in mice compared to the nasal titer obtained at the same time point in this study (106.7 TCID50), using the same inoculation dose (105 TCID50) and a similar Chilean H1N2 IAV-S strain. Moreover, anatomical features of mouse airways are different from that of humans [11], and sialic acid α2,6-Gal receptor is rarely detected in the upper respiratory tract of BALB/c mice [21]. On the other hand, ferret is a validated model that is susceptible to influenza infection and develops symptoms similar to those of humans [27]. Nonetheless, the high cost and lack of commercial availability of ferrets in countries like Chile is a great disadvantage for the use of these animals. Although one limitation of the guinea pig model is the lack of clinical signs due to influenza infection [28], it is a valuable model for assessing viral replication, shedding and transmission.

Overall, these results highlight the guinea pig model as a useful tool to assess novel IAVs-S circulating in swine. Recently, other H1 IAVs-S classified within the human seasonal lineage 1B.2 have also been identified in Argentina, Brazil, China, Mexico, and Vietnam, highlighting the need to characterize these viruses more thoroughly [16]. Hence, guinea pigs could be used to further characterize these IAVs-S in challenge and transmission studies, to evaluate their zoonotic potential, and for the development and updating of IAV-S vaccines. Furthermore, studies related to genetic diversity and distribution of IAV in swine and human population in Chile and the region are necessary to fully evaluate the zoonotic potential of these viruses.

Abbreviations

CPE: 

cytopathic effect

HA: 

hemagglutinin

IAV: 

influenza A virus

M: 

matrix

MDCK: 

Madin-Darby Canine Kidney

PBS: 

phosphate-buffered saline

PBS-PSA-BSA: 

PBS containing 100 units/mL penicillin G, 100 µg/mL streptomycin sulfate, 250 ng/mL amphotericin B and 0.3% bovine serum albumin

pdmH1N1: 

pandemic H1N1

TCID50

median tissue culture infective dose

TPCK: 

N-tosyl-l-phenylalanyl chloromethyl ketone

Declarations

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RT, SB, RAM and VN designed the study and contributed to the interpretation of the data. RT, VG and VN isolated and grew the viruses. RT, VG, RAM and VN collaborated in the process to send the viruses for sequencing (including RNA purification and M-RTPCR). RT, VG, JM, SB and VN looked after the animals and collaborated to obtain the samples. RT and JM carried out the virus titration. RT performed the ELISA, analyzed the data and performed the statistical analyzes. RT, JM and VN performed the phylogenetic analyzes. RT and VN made the figures. RT wrote the manuscript and all the authors contributed to revise and draft it. All authors read and approved the final manuscript.

Acknowledgements

We thank Dr Marcela Triviño and Dr Claudia Lopez from the Instituto de Salud Pública de Chile for kindly providing guinea pigs used in this study. We are grateful to Miguel Vivar from the Animal Virology Lab, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, and Raveen Rathnasinghe from the Centro de Investigaciones Médicas, Pontificia Universidad Católica de Chile, for technical assistance.

Authors’ information

RT is Doctor in Veterinary Medicine (DVM) and Ph.D. candidate (PhDc). His research is focused in the genetic and antigenic diversity of swine influenza viruses, with development of experimental vaccines. Moreover, he also has worked in avian influenza viruses and avian paramyxoviruses in wildlife, and other swine viruses like porcine reproductive and respiratory syndrome virus and porcine circoviruses.

Availability of data and materials

Nucleic acid sequences are available in the GenBank repository [13]. The GenBank accession numbers and the remaining datasets supporting the conclusions of this article are provided within the article (and its additional files).

Ethics approval and consent to participate

Animal procedures were approved by Institutional Animal Care and Use Committees of the Universidad de Chile, under protocol number 02-2016.

Funding

CONICYT-PCHA/Doctorado Nacional/2014-21140719 to RT: funded maintenance for RT and reagents; FIV 2017 and Fondecyt Initiation 11170877 to VN: funded maintenance for VN and reagents; CONICYT-PIA ANILLO ACT 1408 to RAM and VN: funded reagents for RAM and VN; and Center for Research in Influenza Pathogenesis (CRIP), a National Institute of Allergy and Infectious Diseases–funded Center of Excellence in Influenza Research and Surveillance (CEIRS), contract number HHSN272201400008C to RAM: funded reagents and sequencing.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Departamento de Medicina Preventiva Animal, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santa Rosa, 11735 Santiago, Chile
(2)
Programa de Doctorado en Ciencias Silvoagropecuarias y Veterinarias, Universidad de Chile, Santa Rosa, 11735 Santiago, Chile
(3)
Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
(4)
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
(5)
Millennium Institute on Immunology and Immunotherapy, 391 Marcoleta, Santiago, Chile

References

  1. Nelson MI, Wentworth DE, Culhane MR, Vincent AL, Viboud C, LaPointe MP, Lin X, Holmes EC, Detmer SE (2014) Introductions and evolution of human-origin seasonal influenza A viruses in multinational swine populations. J Virol 88:10110–10119View ArticlePubMedPubMed CentralGoogle Scholar
  2. Nelson MI, Viboud C, Vincent AL, Culhane MR, Detmer SE, Wentworth DE, Rambaut A, Suchard MA, Holmes EC, Lemey P (2015) Global migration of influenza A viruses in swine. Nat Commun 6:6696View ArticlePubMedPubMed CentralGoogle Scholar
  3. Vincent A, Awada L, Brown I, Chen H, Claes F, Dauphin G, Donis R, Culhane M, Hamilton K, Lewis N, Mumford E, Nguyen T, Parchariyanon S, Pasick J, Pavade G, Pereda A, Peiris M, Saito T, Swenson S, Van Reeth K, Webby R, Wong F, Ciacci-Zanella J (2014) Review of influenza A virus in swine worldwide: a call for increased surveillance and research. Zoonoses Public Health 61:4–17View ArticlePubMedGoogle Scholar
  4. Nelson M, Culhane MR, Rovira A, Torremorell M, Guerrero P, Norambuena J (2015) Novel human-like influenza A viruses circulate in swine in Mexico and Chile. PLoS Curr. https://doi.org/10.1371/currents.outbreaks.c8b3207c9bad98474eca3013fa933ca6 PubMedPubMed CentralView ArticleGoogle Scholar
  5. Steel J, Staeheli P, Mubareka S, García-Sastre A, Palese P, Lowen AC (2010) Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol 84:21–26View ArticlePubMedGoogle Scholar
  6. Thangavel RR, Bouvier NM (2014) Animal models for influenza virus pathogenesis, transmission, and immunology. J Immunol Methods 410:60–79View ArticlePubMedGoogle Scholar
  7. Zhang H, Li X, Ma R, Li X, Zhou Y, Dong H, Li X, Li Q, Zhang M, Liu Z, Wei B, Cui M, Wang H, Gao J, Yang H, Hou P, Miao Z, Chai T (2013) Airborne spread and infection of a novel swine-origin influenza A (H1N1) virus. Virol J 10:204View ArticlePubMedPubMed CentralGoogle Scholar
  8. Wiersma LC, Vogelzang-van Trierum SE, van Amerongen G, van Run P, Nieuwkoop NJ, Ladwig M, Banneke S, Schaefer H, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF (2015) Pathogenesis of infection with 2009 pandemic H1N1 influenza virus in isogenic guinea pigs after intranasal or intratracheal inoculation. Am J Pathol 185:643–650View ArticlePubMedGoogle Scholar
  9. Lowen AC, Mubareka S, Tumpey TM, García-Sastre A, Palese P (2006) The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A 103:9988–9992View ArticlePubMedPubMed CentralGoogle Scholar
  10. Tang X, Chong KT (2009) Histopathology and growth kinetics of influenza viruses (H1N1 and H3N2) in the upper and lower airways of guinea pigs. J Gen Virol 90:386–391View ArticlePubMedGoogle Scholar
  11. Canning BJ, Chou Y (2008) Using guinea pigs in studies relevant to asthma and COPD. Pulm Pharmacol Ther 21:702–720View ArticlePubMedPubMed CentralGoogle Scholar
  12. World Health Organization. http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/. Accessed 17 May 2018
  13. GenBank. https://www.ncbi.nlm.nih.gov/genbank/. Accessed 10 Apr 2018
  14. Basic Local Alignment Search Tool (BLAST). https://blast.ncbi.nlm.nih.gov/Blast.cgi. Accessed 10 Apr 2018
  15. Influenza Research Database (IRD). https://www.fludb.org/brc/home.spg?decorator=influenza. Accessed 10 Apr 2018
  16. Anderson TK, Macken CA, Lewis NS, Scheuermann RH, Reeth KV, Brown IH, Swenson SL, Simon G, Saito T, Berhane Y, Ciacci-Zanella J, Pereda A, Davis CT, Donis RO, Webby RJ, Vincent AL (2016) A phylogeny-based global nomenclature system and automated annotation tool for H1 hemagglutinin genes from swine influenza A viruses. mSphere 1:e00275–e00316View ArticlePubMedPubMed CentralGoogle Scholar
  17. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, Wentworth DE (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza A viruses. J Virol 83:10309–10313View ArticlePubMedPubMed CentralGoogle Scholar
  18. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493–497View ArticleGoogle Scholar
  19. Wang Z, Yang H, Chen Y, Tao S, Liu L, Kong H, Ma S, Meng F, Suzuki Y, Qiao C, Chen H (2017) A single-amino-acid substitution at position 225 in HA alters the transmissibility of Eurasian avian-like H1N1 swine influenza virus in guinea pigs. J Virol 91:e00800–e00817PubMedPubMed CentralGoogle Scholar
  20. Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, García-Sastre A, Palese P, Hai R (2011) The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol 85:11235–11241View ArticlePubMedPubMed CentralGoogle Scholar
  21. Sun Y, Bi Y, Pu J, Hu Y, Wang J, Gao H, Liu L, Xu Q, Tan Y, Liu M, Guo X, Yang H, Liu J (2010) Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses. PLoS One 5:e15537View ArticlePubMedPubMed CentralGoogle Scholar
  22. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/flu/spotlights/h1n2v-cases-mn.htm. Accessed 10 Apr 2018
  23. Epperson S, Jhung M, Richards S, Quinlisk P, Ball L, Moll M, Boulton R, Haddy L, Biggerstaff M, Brammer L, Trock S, Burns E, Gomez T, Wong KK, Katz J, Lindstrom S, Klimov A, Bresee JS, Jernigan DB, Cox N, Finelli L, Influenza A (H3N2)v Virus Investigation Team (2013) Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis 57(Suppl 1):S4–S11View ArticlePubMedGoogle Scholar
  24. Resende PC, Born PS, Matos AR, Motta FC, Caetano BC, Debur MD, Riediger IN, Brown D, Siqueira MM (2017) Whole-genome characterization of a novel human influenza A(H1N2) virus variant, Brazil. Emerg Infect Dis 23:152–154View ArticlePubMedPubMed CentralGoogle Scholar
  25. Bravo-Vasquez N, Karlsson EA, Jimenez-Bluhm P, Meliopoulos V, Kaplan B, Marvin S, Cortez V, Freiden P, Beck MA, Hamilton-West C, Schultz-Cherry S (2017) Swine influenza virus (H1N2) characterization and transmission in ferrets, Chile. Emerg Infect Dis 23:241–251View ArticlePubMedPubMed CentralGoogle Scholar
  26. Neira V, Brito B, Mena J, Culhane M, Apel MI, Max V, Perez P, Moreno V, Mathieu C, Johow M, Badia C, Torremorell M, Medina R, Ortega R (2017) Epidemiological investigations of the introduction of porcine reproductive and respiratory syndrome virus in Chile, 2013–2015. PLoS ONE 12:e0181569View ArticlePubMedPubMed CentralGoogle Scholar
  27. Belser JA, Katz JM, Tumpey TM (2011) The ferret as a model organism to study influenza A virus infection. Dis Model Mech 4:575–579View ArticlePubMedPubMed CentralGoogle Scholar
  28. Bouvier NM, Lowen AC (2010) Animal models for influenza virus pathogenesis and transmission. Viruses 2:1530–1563View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement